The introduction of glucagon-like peptide-1 (GLP-1) receptor agonists, akin to semaglutide (Ozempic and Wegovy) is a breakthrough within the administration of weight problems. These medicines have confirmed to be very efficient in selling weight reduction and enhancing blood sugar ranges.
Whereas lots of people might imagine that I’ve one thing in opposition to GLP-1s – whether or not as a result of they’re ‘competitors’ for my follow (they aren’t), or that possibly I don’t agree with utilizing prescription drugs over weight-reduction plan for weight reduction. I wrote all about that right here.
I consider the brand new class of weight reduction medicines are unimaginable instruments that can assist to alter folks’s lives for the higher. However they aren’t the complete puzzle; they’re solely only a piece, and there are some very actual limitations to their use.
Current analysis suggests that weight problems charges within the US have dropped very barely – from 46% in 2022 to 45.6% in 2023. There was a 700% enhance in the usage of GLP-1 agonist medicines between 2019 and 2023.
Though even a 0.04% change in weight problems charges could point out a basic downward development which may be attributed partly to GLP-1 medicines, there are good causes to consider that these medicine is not going to drastically cut back the prevalence of weight problems…at the very least, not now. However why?
The reply to this query is multifaceted and sophisticated.
Limitations of GLP-1 Drugs in Addressing Inhabitants-Extensive Epidemic
Value and Accessibility: These medicines are tremendous costly – as in, over $15,000 a yr in some circumstances. It is a large barrier for individuals who can’t afford to pay out of pocket, or who don’t have personal insurance coverage protection. Even for these with personal insurance coverage, corporations usually cap spending or period for GLP-1 medicines. Whereas some folks qualify for GLP-1 meds by means of Medicare or Medicaid, many don’t.
A latest listening to of the US Senate Committee on Well being, Schooling, Labor, and Pensions revealed that Ozempic prices 15x extra in america than in Germany. Information on affected person discontinuation of GLP-1 receptor agonist medicines is inconclusive, however numbers vary from round 50% inside 3 months to 75% by the two yr mark. The explanations for going off the meds embody price, unwanted effects, or sluggish weight reduction.
In different phrases, so many individuals who would probably profit drastically from these medicines, simply can’t entry them in any respect, or for lengthy sufficient. Entry is decrease for folks in sure racial and ethnic teams, that are additionally the teams which have the best charges of weight problems (and the bottom entry to healthcare total).
The patents for a number of of those medicines are up in March, 2026, that means that cheaper generic variations of semaglutide will probably be available on the market shortly after that. Will they be rather more reasonably priced? Solely time will inform.
Sustainability of Results: Whereas GLP-1 medicines are efficient for weight reduction, analysis means that these medicines are in all probability a long-term dedication. For many individuals, their advantages are contingent on continued use. A examine from the STEP 1 trial highlighted that two-thirds of the load misplaced utilizing semaglutide was regained inside a yr after therapy discontinuation. Because the numbers point out, some weight regain is probably going, however that’s not essentially true for everybody.
Once I work with purchasers who’re on GLP-1 agonist medicines, we focus not solely on meals, but additionally on relationship with meals and with life-style modifications akin to rising bodily exercise.
Limitations on Efficacy of GLP-1 Agonist Drugs: Based on Dr. Spencer Nadolsky, D.O. and Weight problems and Lipid Specialist, these meds do have their limits.
Proper now, the typical is round 20% weight reduction with Tizepatide (Mounjaro). For a 400 pound individual, that may imply 80 kilos misplaced. That individual nonetheless has weight problems.
Along with this, Dr. Nadolsky strengthened the truth that not everybody responds to those medicines.
Root Causes of Weight problems: Weight problems is pushed by complicated elements, together with socioeconomic disparities, meals system points, and sedentary life. Conversely, GLP-1 medicines primarily goal processes akin to urge for food regulation and insulin sensitivity. These are clearly vital, however to essentially impact change on weight problems charges, there ought to be a complete focus not solely on pharmacology, but additionally public well being interventions. A 2023 overview in Nature Drugs proposed that initiatives to handle this challenge which have 4 elements: informing the general public about diet, enabling them to make health-promoting selections, motivating them to make modifications to their routines and habits, and influencing behaviour by way of social norms and different strategies.
The overview prompt rising energetic transport, rising healthcare payor incentives, enhancing entry to and affordability of wholesome meals, limiting availability and media advertising and marketing of high-calorie meals, enhancing meals labeling, reformulating meals merchandise to be extra healthful, and rising entry to weight administration packages and bariatric surgical procedure.
Aspect Results and Contraindications: Frequent unwanted effects of GLP-1 medicines, akin to nausea, vomiting, and gastrointestinal discomfort, can deter adherence. Moreover, these medicine are contraindicated for people with sure circumstances, akin to kidney illness, sure cancers, and a historical past of pancreatitis.
The Position of Dietary Interventions
GLP-1 medicines are efficient for most individuals, however modifications in weight-reduction plan do must be a part of their use. Dietary methods can improve the efficacy of therapy whereas supporting long-term well being.
Listed below are some ideas for consuming whereas on a GLP-1 medicines:
Prioritize Protein and Fiber: GLP-1 medicines sluggish gastric emptying, selling early satiety. Which means that most meals and snacks ought to be nutrient-dense to keep away from nutrient deficiencies and promote total well being. A weight-reduction plan wealthy in lean proteins (e.g., meat and fish, tofu, eggs, Greek yogurt and ricotta, beans and lentils) helps to take care of muscle mass. Getting ~25+ grams of fiber per day from greens, complete grains, and fruits, helps maintain fullness and helps blood sugar management. Don’t sleep on beans or soy meals as a solution to get high-quality protein and fibre in a single place!
Reduce Extremely-Processed Meals: Processed meals excessive in refined carbohydrates, added sugars, and unhealthy fat can counteract the advantages of GLP-1 medicines. I like to recommend specializing in complete, minimally processed meals to enhance total metabolic well being. That additionally means minimizing alcohol and different lower-quality meals to assist maximize vitamins in your weight-reduction plan.
Hydration and Small, Frequent Meals: Individuals on GLP-1 medicines usually expertise nausea, which may be mitigated by staying hydrated and consuming smaller, extra frequent meals. On nauseous days, incorporating meals which can be mild on the abdomen, akin to soups and smoothies, may also help.
Conscious Consuming Practices: GLP-1 medicines cut back urge for food, creating a chance to follow conscious consuming. Slowing down throughout meals, savoring meals, and listening to starvation cues may also help reinforce wholesome consuming behaviors.
Rising Weight Loss Drugs
Along with current GLP-1 receptor agonists, a number of promising weight reduction medicines are underneath improvement or awaiting approval:
- Orforglipron Eli Lilly is creating Orforglipron, an oral GLP-1 receptor agonist. This medicine might present an alternate for sufferers preferring to not use injectables.
- CagriSema (Cagrilintide/Semaglutide Mixture) Novo Nordisk is advancing this mixture remedy, displaying vital weight reduction results in early trials.
- Retatrutide Retatrutide is a triple-hormone receptor agonist, with early research reporting substantial weight discount.
- VK2735 Viking Therapeutics is exploring VK2735, an oral remedy with promising preliminary outcomes.
Conclusion
GLP-1 medicines provide vital advantages for people combating weight problems, however they don’t seem to be a panacea for the broader epidemics. Addressing these complicated, multifactorial challenges requires a complete method that mixes medical innovation with strong public well being efforts. By integrating dietary methods, selling equitable entry to care, and tackling systemic points, we will make significant progress towards reversing the tendencies in weight problems.
Are you in search of assist together with your diet? I’m taking new purchasers in my 1:1 follow. Get extra info and ebook a session right here.
Do you know? I even have a web based course for diet in perimenopause and menopause referred to as Don’t Sweat It. Get extra info and join right here.
